Cargando…

Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas

This review covers the literature between 1989 and 2007 on studies relevant to the neuro-oncology usage of eflornithine (α-difluoromethylornithine), an oral agent that irreversibly inhibits the enzyme ornithine decarboxylase. It covers the use of eflornithine, alone or in combination, to treat high-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levin, Victor A, Ictech, Sandra E, Hess, Kenneth R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977277/ https://www.ncbi.nlm.nih.gov/pubmed/29378419 http://dx.doi.org/10.2217/cns-2017-0031

Ejemplares similares

Impact of phase II trials with progression-free survival as end-points on survival-based phase III studies in patients with anaplastic gliomas
por: Levin, Victor A, et al.
Publicado: (2007)

Effect of eflornithine on mutation frequency in temozolomide-treated U87MG cells
por: Yam, Noymi, et al.
Publicado: (2020)

Metastasis of hormone-independent breast cancer to lung and bone is decreased by α-difluoromethylornithine treatment
por: Richert, Monica M, et al.
Publicado: (2005)

α-Difluoromethylornithine-Induced Cytostasis is Reversed by Exogenous Polyamines, Not by Thymidine Supplementation
por: Hyvönen, Mervi T., et al.
Publicado: (2021)

Enantiospecific antitrypanosomal in vitro activity of eflornithine
por: Boberg, Mikael, et al.
Publicado: (2021)

Difluoromethylornithine (DFMO) and Neuroblastoma: A Review
por: Tangella, Adarsh Vardhan, et al.
Publicado: (2023)

720. Efficacy of Nifurtimox + Eflornithine in the Treatment of African Trypanosomiasis. Systematic Review
por: Hidalgo, Jessica, et al.
Publicado: (2021)

A Molecular Mechanism for Eflornithine Resistance in African Trypanosomes
por: Vincent, Isabel M., et al.
Publicado: (2010)

Therapy of murine squamous cell carcinomas with 2-difluoromethylornithine
por: Chen, Yan, et al.
Publicado: (2004)

Effect of an Inhibitor of Tumor Promotion, α‐Difluoromethylornithine, on Tumor Induction by Repeated Beta Irradiation in Mice
por: Ootsuyama, Akira, et al.
Publicado: (1993)

The First Insight Into the Supramolecular System of D,L-α-Difluoromethylornithine: A New Antiviral Perspective
por: Bojarska, Joanna, et al.
Publicado: (2021)

Difluoromethylornithine rebalances aberrant polyamine ratios in Snyder–Robinson syndrome
por: Stewart, Tracy Murray, et al.
Publicado: (2023)

Difluoromethylornithine (DFMO) and AMXT 1501 inhibit capsule biosynthesis in pneumococci
por: Ayoola, Moses B., et al.
Publicado: (2022)

A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda
por: Kansiime, Freddie, et al.
Publicado: (2018)

Difluoromethylornithine (DFMO) Enhances the Cytotoxicity of PARP Inhibition in Ovarian Cancer Cells
por: El Naggar, Olivia, et al.
Publicado: (2022)

Alpha-Difluoromethylornithine, an Irreversible Inhibitor of Polyamine Biosynthesis, as a Therapeutic Strategy against Hyperproliferative and Infectious Diseases
por: LoGiudice, Nicole, et al.
Publicado: (2018)

Chiral Chromatographic Isolation on Milligram Scale of the Human African Trypanosomiasis Treatment d- and l-Eflornithine
por: Boberg, Mikael, et al.
Publicado: (2020)

Efficacy and Toxicity of Fexinidazole and Nifurtimox Plus Eflornithine in the Treatment of African Trypanosomiasis: A Systematic Review
por: Hidalgo, Jessica, et al.
Publicado: (2021)

Combined Use of α‐Difluoromethylornithine and an Inhibitor of S‐Adenosylmethionine Decarboxylase in Mice Bearing P388 Leukemia or Lewis Lung Carcinoma
por: Nakaike, Shiro, et al.
Publicado: (1988)

Safety and efficacy of hydroxyurea and eflornithine against most blood parasites Babesia and Theileria
por: El-Saber Batiha, Gaber, et al.
Publicado: (2020)

Application of Hantzsch reaction for sensitive determination of eflornithine in cream, plasma and urine samples
por: Almahri, Albandary, et al.
Publicado: (2021)

Use of Eflornithine (DFMO) in the Treatment of Early Alzheimer's Disease: A Compassionate Use, Single-Case Study
por: Alber, Jessica, et al.
Publicado: (2018)

Nifurtimox plus Eflornithine for Late-Stage Sleeping Sickness in Uganda: A Case Series
por: Checchi, Francesco, et al.
Publicado: (2007)

Eflornithine Hydrochloride-Loaded Electrospun Nanofibers as a Potential Face Mask for Hirsutism Application
por: Almuwallad, Shuruq S., et al.
Publicado: (2023)

In-Hospital Safety in Field Conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. b. gambiense Sleeping Sickness
por: Schmid, Caecilia, et al.
Publicado: (2012)

Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas
por: Raj, K P, et al.
Publicado: (2013)

Untargeted Metabolomics Reveals a Lack Of Synergy between Nifurtimox and Eflornithine against Trypanosoma brucei
por: Vincent, Isabel M., et al.
Publicado: (2012)

The Polyamine Inhibitor Alpha-Difluoromethylornithine Modulates Hippocampus-Dependent Function after Single and Combined Injuries
por: Rosi, Susanna, et al.
Publicado: (2012)

Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer
por: Janakiram, Naveena B., et al.
Publicado: (2016)

Repurposing eflornithine to treat a patient with a rare ODC1 gain-of-function variant disease
por: Rajasekaran, Surender, et al.
Publicado: (2021)

DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27(Kip1) activity in neuroblastoma
por: KOOMOA, DANA-LYNN T., et al.
Publicado: (2013)

Difluoromethylornithine Is a Novel Inhibitor of Helicobacter pylori Growth, CagA Translocation, and Interleukin-8 Induction
por: Barry, Daniel P., et al.
Publicado: (2011)

Difluoromethylornithine attenuates isoproterenol-induced cardiac hypertrophy by regulating apoptosis, autophagy and the mitochondria-associated membranes pathway
por: Zhao, Yu, et al.
Publicado: (2021)

Role of obesity in a randomized placebo-controlled trial of difluoromethylornithine (DFMO) + sulindac for the prevention of sporadic colorectal adenomas
por: Zell, Jason A., et al.
Publicado: (2012)

Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma
por: Kiyokawa, Juri, et al.
Publicado: (2019)

Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6
por: Baker, Nicola, et al.
Publicado: (2011)

The blood–brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brain(1)
por: Sanderson, Lisa, et al.
Publicado: (2008)

Glioma Stem Cells and Immunotherapy for the Treatment of Malignant Gliomas
por: Toda, Masahiro
Publicado: (2013)

Oligoamine analogues in combination with 2-difluoromethylornithine synergistically induce re-expression of aberrantly silenced tumour-suppressor genes
por: Wu, Yu, et al.
Publicado: (2012)

Inhibiting Cycloxygenase and Ornithine Decarboxylase by Diclofenac and Alpha-Difluoromethylornithine Blocks Cutaneous SCCs by Targeting Akt-ERK Axis
por: Arumugam, Aadithya, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ll39riu5amjjlmv0st0pnpmld1